← Evidence map

ArticleBioMed research international2026

RETRACTION: Upregulation of miR-138 Increases Sensitivity to Cisplatin in Hepatocellular Carcinoma by Regulating EZH2.

BioMed Research InternationalPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

RETRACTION: Upregulation of miR-138 Increases Sensitivity to Cisplatin in Hepatocellular Carcinoma by Regulating EZH2. | OpenQuestion